News Chart Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE 04:00:00 2026-10-23 pm EDT			5-day change	1st Jan Change
1.610 ^USD	-28.76%		-25.81%	-41.45%

Oct. 23	Perspective Therapeutics, Inc. Announces New Interim Results From Ongoing Phase 1/2a Clinical Trial Of [212Pb]VMT-a-NET In Advanced SSTR2-Expressing NETs	CI
Oct. 23	Perspective Reports 'Encouraging' Bamzireotide Profile in Tumor Trial	MT

53.IeclN1Qt9ivLYOkNTNHNZiafu58UeF_8QpkVW0XNZzY.GJVdWQFskG36Gp5gAJn1FHDAyrJQMBHRHcNsHi-1X3JQrWNHIRy4SYZWng~0173067d71c8fa0fdaf56adefd67c254